CIE-10

CIE-10-código E21

You are here: Inicio > CIE-10 > E00-E89 > E20-E35

- CIE-10
Clasificación Internacional de Enfermedades
- E00-E89
Enfermedades endocrinas, nutricionales y metabolicas
- E20-E35
Trastornos de otras glándulas endocrinas

E21

Hiperparatiroidismo y otros trastornos de la glándula paratiroides

CIE-10 Сódigo E21 para Hiperparatiroidismo y otros trastornos de la glándula paratiroides

Excluye: osteomalacia:

• del adulto (M83.–)

• infantil y juvenil (E55.0)

E21.0
Hiperparatiroidismo primario
E21.1
Hiperparatiroidismo secundario no clasificado en otra parte
E21.2
Otros tipos de hiperparatiroidismo
E21.3
Hiperparatiroidismo, sin otra especificación
E21.4
Otros trastornos especificados de la glándula paratiroides
E21.5
Trastorno de la glándula paratiroides, no especificado
ICD-10
ATC
ICD-10 International Statistical Classification of Diseases and Related Health Problems 10th Revision
ICD-10

ICD-10 is the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD), a medical classification list by the World Health Organization (WHO).

It contains codes for diseases, signs and symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or diseases.

ATC

The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.

It is controlled by the World Health Organization Collaborating Centre for Drug Statistics Methodology (WHOCC).

DDD

The defined daily dose (DDD) is a statistical measure of drug consumption, defined by the World Health Organization (WHO).

It is used to standardize the comparison of drug usage between different drugs or between different health care environments.

Home Contact Us